AbbVie · 2 weeks ago
2026 AI/ML Biotherapeutics Development Intern (PhD)
AbbVie is a pharmaceutical company focused on discovering and delivering innovative medicines. The AI/ML Biotherapeutics Development Internship involves working with a team to enhance biologics property prediction using AI/ML methods and collaborating with experts in the field.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Evaluate and analyze structures of biologics
Explore and implement state-of-the-art techniques to improve AI/ML models
Collaborate with AI/ML and computational biology experts to refine modeling strategies and achieve predefined success metrics
Qualification
Required
Currently enrolled in university, pursuing a PhD in Computer Science, Computational Biology, Biophysics, or other related field
Must be enrolled in university for at least one semester following the internship
Demonstrated experience with deep learning concepts and experience with Python and PyTorch
Familiarity with protein language models
Familiarity with protein structure data (e.g., PDB files) and structural biology concepts
Excellent communication, problem-solving, and collaboration skills
Preferred
Expected graduation date between December 2026 – June 2027
Antibody-related knowledge
Experience with molecular dynamic simulations or other protein structural sampling techniques
Experience with Graph Neural Network (GNN) models
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-09
2026-01-08
Morningstar.com
2026-01-08
Company data provided by crunchbase